Yeast Origin rhEGF Epidermal Growth Factor PH 6.5-7.5 Non - Animal Component

Yeast Origin rhEGF Epidermal Growth Factor PH 6.5-7.5 Non - Animal Component ​

Description

Healthgen Biotech has been committed in protein purification research and made a breakthrough in 2015. We have achieved more than 10 patents about the ourification technology. Now, our rhEGF purity can reach more than 98%. Healthgen Biotech facility is compliance with the GMP standard, with many advantages such as animal component free, high purity, low endotoxin and so on.

Quick detail

1. CAS No.: 62253-63-8
2. Other Names: rhEGF​, Recombinant epidermal growth factor, recombinant EGF, rEGF, EGF
3. EINECS No.: 263-468-7
4. Place of Origin: Wuhan, China (Mainland)
5. Brand Name: Oryzogen
6. Model Number: HYC020M01
7. Formulation: rEGF is lyophilized with mannitol as the stabilizer
8. Storage and Handling: Stored at temperatures -20℃ for 24 months

Physiological and Biochemical Properties of our rhEGF and rEGF(E.coli)

Advantages

1. Healthgen Biotech recombinant Human Epidermal Growth Factor (rhEGF) has excellent batch consistency. Using the world-leading purification technology to purify the rhEGF, Healthgen Biotech can ensure the excellent consistency of rhEGF from different batches.

2. Healthgen Biotech recombinant Human Epidermal Growth Factor is free of animal origin, which effectively avoid any potential risk of animal bacteria, prions, virus and contagious protein disease.

3. Healthgen Biotech has a professional quality control department, in which 50% of them have master's degree or higher. There are 14 employees in the quality department, 9 of them are in QA and 5 are in QA. All of them have rich experience in analysis research or quality inspection. Half of them have graduated diploma. Every year there are more than 50 training courses, which cover GMP, SOP, specification, hygiene, QA, QC issues, etc.

Supplemental Description

EGF is a potent growth factor that stimulates the proliferation of various epidermal and epithelial cells. Additionally, EGF has been shown to inhibit gastric secretion, and to be involved in wound healing. EGF signals through a receptor known as c-erbB, which is a class I tyrosine kinase receptor. This receptor also binds with TGF-α and VGF (vaccinia virus growth factor). Recombinant human EGF is a 6.3 kDa globular protein containing 53 amino acid residues including 3 intramolecular disulfide-bonds. Manufactured using all non-animal reagents.